CRISPR 기술 시장 규모, 점유율, 성장 분석 : 제품·서비스별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global CRISPR Technology Market size was valued at USD 3.50 Billion in 2024 and is poised to grow from USD 4.08 Billion in 2025 to USD 13.84 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).

The global CRISPR technology market is experiencing significant growth driven by advancements in genome editing capabilities. This revolutionary tool enables precise modifications of DNA sequences, allowing researchers to address genetic defects, combat diseases, and enhance agricultural yields. By leveraging synthetic guide RNA and Cas9 nuclease, CRISPR facilitates targeted genomic alterations, including the removal or insertion of genetic components. The rising application of CRISPR in microbiology, coupled with increasing investments in genetic research, reinforces its market potential. Despite this growth, ethical considerations and a scarcity of specialized knowledge present challenges that could hinder further expansion. Applications range from disease treatment to agricultural improvements, highlighting CRISPR's crucial role in modern biotechnology and genetic engineering.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segments Analysis

Global CRISPR Technology Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Products and Services. Based on Application, the market is segmented into Drug discovery & development, Agriculture and Other applications. Based on End User, the market is segmented into Pharmaceutical & biotechnology companies, Academic & research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global CRISPR Technology Market

The growth of the global CRISPR technology market is driven by a multitude of factors that enhance the gene editing sector. An uptick in financial support for genetic research in developed regions like North America and Europe is significantly bolstering market expansion. Government initiatives in these areas are channeling substantial investments into innovative materials, advanced equipment, and novel techniques for genetic exploration. Additionally, such funding fosters the advancement of medical solutions targeting rare genetic disorders. Furthermore, support from entities like the National Human Genome Research Institute in Europe plays a crucial role in propelling genomics research forward, further solidifying the market's potential.

Restraints in the Global CRISPR Technology Market

The Global CRISPR Technology market faces significant constraints primarily due to the high costs associated with CRISPR-based therapies. Developing and manufacturing advanced genome editing treatments require extensive time, resources, and investment, leading to increased expenses. This financial burden ultimately falls on patients, as the accessibility of CRISPR gene detection kits and therapeutic options is limited by their price. Consequently, the high costs hinder widespread adoption and utilization of these innovative technologies, posing a challenge to the overall growth and reach of the CRISPR market as it seeks to serve a diverse population in need of genetic interventions.

Market Trends of the Global CRISPR Technology Market

The Global CRISPR Technology market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) into gene editing processes. This fusion enhances the precision and efficiency of CRISPR applications by improving target identification and minimizing off-target effects. Leveraging advanced data analysis capabilities, AI and ML are accelerating the therapeutic target discovery process within various sectors, including drug development and diagnostics. As these technologies evolve, they are expected to further revolutionize gene editing, fostering innovation in research and expanding the range of potential applications, thereby driving substantial growth in the CRISPR market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global CRISPR Technology Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Products
  • CRISPR kits & Enzymes
  • CRISPR Libraries
  • Other Products
  • Design Tools
  • Antibodies
  • Other Reagents
• Services
  • GRNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Other Services
  • Epigenome Editing
  • Transcriptional Activation

Global CRISPR Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug discovery & development
• Agriculture
• Other applications
  • Biofuels
  • Veterinary

Global CRISPR Technology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Others
  • CROs
  • CDMOs

Global CRISPR Technology Market Size & CAGR (2026-2033)

• North America (Product & Services, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CRISPR Therapeutics (Switzerland/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Integrated DNA Technologies (IDT)) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer Inc.) (UK/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations